Cohort profile: pulmonary early assessment of the lung in paediatric cancer patients (SWISS-PEARL Study)
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: Due to the limited sensitivity of conventional lung function tests in detecting small airway abnormalities, cancer treatment-related pulmonary toxicity may be underdiagnosed. It has been suggested that the nitrogen multiple-breath washout test (N2MBW) might be more sensitive in detecting small airway abnormalities in childhood cancer survivors. Objective: The Pulmonary Early Assessment of the Lung in Paediatric Cancer Patients (SWISS-PEARL) study aims to assess the prevalence and development of early pulmonary toxicity at baseline and longitudinally in paediatric cancer patients using spirometry, body plethysmography, diffusing capacity for carbon monoxide (DLCO), N2MBW and magnetic resonance imaging (MRI) and to identify treatment-related pulmotoxic risk factors. Results: Since May 2022, we have recruited 44 patients and performed 134 lung function tests at baseline. Mean age at diagnosis was 12 years (range 4-18). The most common cancer diagnoses were leukaemia (41%) and lymphoma (23%). Pulmonary assessment was feasible and of good quality in 43/44 (98%) patients for at least one test at baseline; only 4 patients dropped out after baseline measurements. Conclusion: This study will assess the potential development of early pulmonary dysfunction during and post-treatment. Findings from the SWISS-Pearl study may help inform future guidelines for pulmonary surveillance in paediatric cancer patients.
DOI: 10.5167/uzh-282847
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7124708206
FWCI:
Cites:
Cited by:
Related to: